Chronic Insomnia: Clinical Trials

5 trials for Chronic Insomnia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Completed 5
Phase 31Completed 1

Follow Chronic Insomnia: new trials by email Literature Review of Chronic Insomnia trials Research Report on Chronic Insomnia

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Bayesian Adaptive Randomization Design, Dose Response Study of the Efficacy of E2006 in Adults and Elderly Subjects With Chronic Insomnia
E2006, Placebo - Chronic Insomnia, Adults
Phase 2CompletedEisai Inc.2912013-11-132020-01-31
Chamomile for Chronic Primary Insomnia
Chamomile High Grade Extract, Placebo Tablet - Primary Insomnia, Chronic Insomnia
Phase 2CompletedUniversity of Michigan342008-07-012017-11-07
Mindfulness Versus Pharmacotherapy for Chronic Insomnia: A Pilot Study
Mindfulness-Based Stress Reduction, eszopiclone - Chronic Insomnia, Primary Insomnia
Phase 2 / Phase 3CompletedUniversity of Minnesota302007-08-012013-03-29
Efficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's Disease
Ramelteon, Placebo - Chronic Insomnia
Phase 2CompletedTakeda742006-03-212017-08-14
Efficacy and Safety of Ramelteon on Chronic Insomnia
Ramelteon and Placebo (25 possible combinations total) - Chronic Insomnia
Phase 2CompletedTakeda662002-05-012010-06-02

Narrower conditions

Sleep Initiation and Maintenance Disorders (5)  ·  Alzheimer Disease (1)

Broader conditions

Dyssomnias (5)  ·  Mental Disorders (5)  ·  Nervous System Diseases (5)  ·  Sleep Disorders, Intrinsic (5)  ·  Sleep Wake Disorders (5)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Dementia (1)  ·  Neurocognitive Disorders (1)  ·  Neurodegenerative Diseases (1)  ·  Tauopathies (1)

Interventions

ramelteon (2)  ·  Eszopiclone (1)  ·  Mindfulness-Based Stress Reduction (1)

Sponsors

Takeda (2)  ·  Eisai Inc. (1)  ·  University of Michigan (1)  ·  University of Minnesota (1)

Countries

United States (4)

Top investigators

Cynthia R Gross, PhD (1)  ·  J. Todd Arnedt, PhD (1)  ·  Mary Jo Kreitzer, RN, PhD (1)  ·  Suzanna M Zick, ND, MPH (1)

Results publications

PMID 21397868, PMID 21939549, PMID 29065953, PMID 33189083